Turning the corner on therapeutic cancer vaccines
RE Hollingsworth, K Jansen - npj Vaccines, 2019 - nature.com
Recent advances in several areas are rekindling interest and enabling progress in the
development of therapeutic cancer vaccines. These advances have been made in target …
development of therapeutic cancer vaccines. These advances have been made in target …
Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies
Telomeres maintain genomic integrity in normal cells, and their progressive shortening
during successive cell divisions induces chromosomal instability. In the large majority of …
during successive cell divisions induces chromosomal instability. In the large majority of …
Progress in human tumour immunology and immunotherapy
SA Rosenberg - Nature, 2001 - nature.com
Studies of the administration of interleukin-2 to patients with metastatic melanoma or kidney
cancer have shown that immunological manipulations can mediate the durable regression …
cancer have shown that immunological manipulations can mediate the durable regression …
Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer
JL Tanyi, S Bobisse, E Ophir, S Tuyaerts… - Science translational …, 2018 - science.org
We conducted a pilot clinical trial testing a personalized vaccine generated by autologous
dendritic cells (DCs) pulsed with oxidized autologous whole-tumor cell lysate (OCDC) …
dendritic cells (DCs) pulsed with oxidized autologous whole-tumor cell lysate (OCDC) …
Therapeutic cancer vaccines: past, present, and future
Therapeutic vaccines represent a viable option for active immunotherapy of cancers that aim
to treat late stage disease by using a patient's own immune system. The promising results …
to treat late stage disease by using a patient's own immune system. The promising results …
Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen
G Denkberg, A Lev, L Eisenbach, I Benhar… - The Journal of …, 2003 - journals.aai.org
Tumor-associated, MHC-restricted peptides, recognized by tumor-specific CD8+
lymphocytes, are desirable targets for novel approaches in immunotherapy because of their …
lymphocytes, are desirable targets for novel approaches in immunotherapy because of their …
[HTML][HTML] Cytotoxic T cells
The immune system is a complex arrangement of cells and molecules that preserve the
integrity of the organism by elimination of all elements judged dangerous. Within the …
integrity of the organism by elimination of all elements judged dangerous. Within the …
Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers
Y Wang, B Deng - Cancer and Metastasis Reviews, 2023 - Springer
Hepatocellular carcinoma (HCC) is a common malignancy and one of the leading causes of
cancer-related death. The biological process of HCC is complex, with multiple factors …
cancer-related death. The biological process of HCC is complex, with multiple factors …
Human T cell responses against melanoma
Many antigens recognized by autologous T lymphocytes have been identified on human
melanoma. Melanoma patients usually mount a spontaneous T cell response against their …
melanoma. Melanoma patients usually mount a spontaneous T cell response against their …
T-cell epitope vaccine design by immunoinformatics
Vaccination is generally considered to be the most effective method of preventing infectious
diseases. All vaccinations work by presenting a foreign antigen to the immune system in …
diseases. All vaccinations work by presenting a foreign antigen to the immune system in …